Virtu Financial LLC Catalyst Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	BUY	$13.18 - $17.11 $157,870 - $204,943	11,978 New	11,978 $191,000
Q3 2022 Nov 07, 2022	BUY	$7.06 - $15.52 $627,577 - $1.38 Million	88,892 New	88,892 $1.14 Million
Q3 2021 Nov 12, 2021	SELL	$4.85 - $6.04 $64,480 - $80,301	-13,295 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$4.29 - $6.05 $57,035 - $80,434	13,295 New	13,295 $76,000
Q4 2020 Feb 24, 2021	SELL	$2.97 - $3.83 $184,205 - $237,544	-62,022 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$2.97 - $5.08 $184,205 - $315,071	62,022 New	62,022 $184,000
Q2 2020 Aug 07, 2020	SELL	$3.48 - $5.05 $37,323 - $54,161	-10,725 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$3.67 - $5.7 $39,360 - $61,132	10,725 New	10,725 $40,000
Q2 2019 Aug 13, 2019	SELL	$2.7 - $6.11 $303,933 - $687,790	-112,568 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$2.11 - $5.33 $17,010 - $42,970	8,062 Added 7.71%	112,568 $574,000
Q4 2018 Jan 16, 2019	BUY	$1.92 - $3.62 $200,651 - $378,311	104,506 New	104,506 $201,000
Q1 2018 May 14, 2018	SELL	$2.39 - $4.01 $40,065 - $67,223	-16,764 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$2.51 - $4.4 $34,156 - $59,875	-13,608 Reduced 44.8%	16,764 $66,000
Q3 2017 Nov 15, 2017	BUY	$2.4 - $2.94 $72,892 - $89,293	30,372	30,372 $0

326

94.6M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.